ECM
BDSX icon

ExodusPoint Capital Management’s Biodesix BDSX Stock Holding History

ExodusPoint Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,072
Closed -$63K – 1627
2024
Q2 		$63K Buy
+2,072
New +$59.2K ﹤0.01% 1442
2024
Q1 		– Sell
-1,198
Closed -$44K – 1493
2023
Q4 		$44K Buy
+1,198
New +$37.6K ﹤0.01% 1387
2021
Q3 		– Sell
-755
Closed -$199K – 2119
2021
Q2 		$199K Buy
+755
New +$237K ﹤0.01% 1988
2021
Q1 		– Sell
-1,951
Closed -$787K – 2122
2020
Q4 		$787K Buy
+1,951
New +$607K 0.01% 987

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

ExodusPoint Capital Management's BDSX Position: Q3 2024 in Review

ExodusPoint Capital Management sold out of Biodesix (BDSX) in Q3 2024, closing a stake of 2,072 shares — an estimated $63K sold.

ExodusPoint Capital Management first reported a position in BDSX in Q4 2020 and held it in 4 quarters. The position peaked at $787K in Q4 2020. 52 funds tracked by Wall St. Rank hold BDSX as of Q3 2024.

  • ExodusPoint Capital Management reported no remaining Biodesix position as of Q3 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 2,072 Biodesix shares in Q3 2024, an estimated $63K.
  • ExodusPoint Capital Management first reported a position in Biodesix in Q4 2020 and held it in 4 quarters.
  • ExodusPoint Capital Management's Biodesix position peaked at $787K in Q4 2020.
  • 52 funds tracked by Wall St. Rank held Biodesix as of Q3 2024.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.